| Logo | Name | Σ | Employees | ||
|---|---|---|---|---|---|
 |  GestSure The GestSure System allows surgeons to control operating room computers while scrubbed using simple hand gestures. GestSure Technologies is creating rich, touchless gestural interfaces that allow surgeons and interventional radiologists to control the equipment around them. Our system works as a layer on top of existing PACS, 3D visualization, or electronic medical records. That means no clumsy software to install and no need to import imaging into a parallel system. Gestural Interfaces, Medical Devices, and Health IT Type: | 3 | 2 | 2 | 1 |
 |  Telo Genomics Genomics Imaging for Precision Medicine Telo Genomics is a biotech company pioneering the most comprehensive telomere platform in the industry with powerful applications and prognostic solutions. These include liquid biopsies and related technologies in oncology and neurological diseases. Liquid biopsy is a rapidly growing field of significant interest to the medical community for being less invasive and more easily replicated than traditional diagnostic approaches. By combining our team’s considerable expertise in quantitative analysis of 3D telomeres with molecular biology and artificial intelligence to recognize disease-associated genetic instability, Telo Genomics is developing simple and accurate products that improve day-to-day care for … Type: | 0 | 0 | 0 | 15 |
 | Vielight Inc. Through neuroscience and engineering, we elevate brain health and performance. Through neuroscience and engineering, we elevate brain health and neural performance with our brain photobiomodulation technology. Published research with our patented technology has produced improvements in cognition, memory and mood. From neurodegeneration to brain performance, we aspire to accelerate photobiomodulation research by collaborating with bright minds globally. neurotechnology, brain photobiomodulation, biohacking, neurofeedback, brain stimulation, wellness technology, alzheimer's research, and traumatic brain injury research Type: | 0 | 0 | 0 | 15 |
 | Intellijoint Surgical Inc. Advancing orthopaedic surgery by providing surgeons with effective, easy-to-use technology. Intellijoint Surgical develops and commercializes surgical navigation solutions for total joint replacements. We are committed to improving patients’ lives by providing every surgeon with effective, easy-to-use technology. Intellijoint HIP and Intellijoint KNEE smart navigation applications are both delivered through the Intellijoint Navigation System. It is a fast and easy-to-use, surgeon-controlled system that provides real-time measurements to optimize implant alignment and positioning during total hip and knee replacement surgery to help improve patient outcomes. Medical Device, Smart Tools, Total Hip Replacement, and Total Hip Arthroplasty Type: | 1 | 0 | 1 | 82 |
 | FREDsense Technologies Water quality monitoring powered by biology. FREDsense is a Calgary-based biotechnology venture developing novel tools for real-time water quality analysis. Our lead product - the Field Ready Electrochemical Detector (FRED) - consists of a genetically engineered bacterium tuned to sense heavy metals and other contaminants. The system is portable, autonomous, and connected, providing users with continuous water quality measurements. Synthetic Biology, Water Quality Monitoring, Cleantech, Biotechnology, Sensors, Instrumentation, and IoT Type: | 0 | 0 | 0 | 23 |
 | Service d’Électro-Thérapie [Automatic translation follows] Relieve your pain. Get back to an active life. Electrotherapy with TENS is scientifically recognized as an effective, safe and complementary solution to medication to control pain. It acts on the body's natural mechanisms through the use of electrodes. Our high-quality devices are designed in Quebec and approved by Health Canada. They are portable and easy to use at home for self-management of pain by patients. We also offer muscle stimulators for healthy muscles and denervated muscles. Our team, made up of members of the Professional Order of Physiotherapy of Quebec and specialized in functional electrotherapy, places … Type: | 1 | 1 | 0 | 36 |
 | ELECTRO-MEDIC [Automatic translation follows] Électro-Médic, proud designer of analgesic devices accessible to all There are a multitude of daily activities, professional or sporting, and the body reacts in the more or less long term and in a very different way from one individual to another, to each of them. Électro-Médic, proud designer (QC, CA), offers therapeutic devices aimed at any user wishing to benefit from a program aimed at a notable reduction in pain and even allowing them, depending on the case, to go about their daily routine. daily occupations! The use and benefits of electrotherapy Much of the excitement surrounding … Type: | 1 | 1 | 1 | 3 |
 | Treventis Corporation TREVENTISTM Corporation is dedicated to treating and preventing protein misfolding diseases. We utilize a proprietary, patent-pending discovery engine – Common Conformational Morphology (CCM) – to identify druggable active sites in misfolded protein targets. CCM combines unique in silico models with deep expertise in model development (in vitro, ex vivo, in vivo) to enable rational drug design against misfolded protein targets. Our lead program focuses on anti-misfolding small molecules in tauopathy (3R, 4R, familial mutations and mixed) with relevance to Alzheimer’s disease. We have further CCM-driven efforts in oncology and other neurodegenerative diseases that show the wide utility of our technology … Type: | 0 | 0 | 0 | 15 |
 | EHN Canada Home to the country's largest network of industry-leading mental health and addiction treatment centres. EHN Canada is the nation's largest network of industry-leading mental health and addiction treatment centres. With over 100 years of collective experience in providing high quality inpatient and outpatient services, EHN Canada provides a comprehensive, compassionate, and truly national therapeutic option to patients, families, healthcare practitioners, and corporate partners. Under the umbrella of EHN Canada, we are able to harness the power of Canada's leading treatment centres for addiction, trauma, and mental health: Edgewood Treatment Center in Nanaimo, BC; Sandstone in Calgary, AB; Bellwood Health Services … Type: | 0 | 0 | 0 | 336 |
 | MediPharm Labs MediPharm Labs was created in 2015 by a handful of industry experts in Ontario. With the medicinal benefits of cannabis firmly established – and with a global patient market demanding quality cannabis oil – MediPharm Labs was born. While initially exploring options to cultivate cannabis plant, MediPharm Labs came to recognize the opportunity for a select focus on cannabis concentrates. MediPharm Labs set out to master this area of production, and rely on the many cultivating experts to provide quality raw materials. In 2016, MediPharm labs submitted an application to Health Canada for approval to distribute medicinal cannabis oil. Proudly, … Type: | 0 | 0 | 0 | 146 |
 | MaSTherCell Now a part of Catalent Cell & Gene Therapy With deep experience in viral vector scale-up and production, Catalent Cell & Gene Therapy is a full-service partner for adeno-associated virus (AAV) and lentiviral vectors, and CAR-T immunotherapies. When it acquired MaSTherCell, Catalent added expertise in autologous and allogeneic cell therapy development and manufacturing to position it as a premier technology, development and manufacturing partner for innovators across the entire field of advanced biotherapeutics. Catalent has a global cell and gene therapy network of dedicated, large-scale clinical and commercial manufacturing facilities, and fill-finish and packaging capabilities located in both the U.S. … Type: | 1 | 1 | 1 | 26 |
 |  OncoDNA Genomic and theranostic company specializing in precision medicine for the treatment of cancer and genetic diseases OncoDNA is a genomic and theranostic company specializing in precision medicine for the treatment of cancer and genetic diseases. The company helps clinicians, academic researchers and biopharma companies to outsmart molecular complexity with the mission of delivering the promise of precision medicine. The company not only provides clinical guidance for the treatment and real-time monitoring of late-stage cancer patients but also supports research and drug development in cancer and genetic diseases. Since its early days in 2012, OncoDNA has grown into a corporate group … Type: | 5 | 2 | 4 | 113 |
 | Digital Orthopaedics Clinical decision support systems for musculoskeletal pathologies Digital Orthopaedics is a Digital Health company with the mission to provide a comprehensive Clinical Decision Support System (CDSS) for musculoskeletal pathologies, the foot and ankle in particular. our ambition is to transforms the planning and execution of orthopedic surgeries and treatment with the ultimate goal of Personalizing Orthopedic Treatment through the innovative use of ideation, modeling and 3D simulation. We provide surgeons, patients, and medical devices companies with a state of the art CDSS to identify the optimal treatment and surgical therapeutic plan for each patient and to assist medical device companies … Type: | 0 | 0 | 0 | 4 |
 | Cellaïon Cell Signaling Technology for Organ Repair and Regeneration Cell Signaling Technology for Organ Repair and Regeneration We care for liver Our advanced therapy aims to restore liver function thanks to immunomodulatory and regenerative properties of Hepastem Cell therapy, Acquired liver diseases, Liver diseases, liver based genetic diseases, NASH, ACLF, Antibodies, Clinical stage, Chronic liver disease, Fatty liver, Acute liver disease, Regenerative medicine, Biotech, and Biotechnology Type: | 2 | 1 | 1 | 51 |
 | 3P Biopharmaceuticals We are now 3PBIOVIAN! Follow us on our new LinkedIn page, 3PBIOVIAN, to stay updated on all the latest developments and news! 3P Biopharmaceuticals and Biovian join forces to create 3PBIOVIAN, a leading pan-European biologics CDMO. Read more here: www.3pbiovian.com ***** 3PBIOVIAN is a globally operating Contract Development and Manufacturing Organization (CDMO), delivering end-to-end services for biotech and pharma companies. Our service offering includes microbial and mammalian protein expression platforms, viral vector production for adenoviruses and adeno-associated viruses, cell therapy, and plasmid DNA production. Additionally, we provide fill and finish services for recombinant proteins and viral vectors. With a combined … Type: | 2 | 0 | 1 | 230 |
 | Groupe d'Étude et de Promotion des Protéines Végétales [Automatic translation follows] Long live plant proteins! The GEPV, with the support of interprofessional organizations, supports the development of plant proteins by actively participating in a better knowledge of these products. VPMs (plant protein materials) are food ingredients derived from protein-rich plant species, such as legume seeds (soybean, udder, lupine, faba bean) and cereal seeds (wheat). Type: | 5 | 1 | 5 | N/A |
 | Sebia France [Automatic translation follows] The world leader in protein separation using innovative electrophoresis systems Sebia is the world leader in protein separation using innovative electrophoresis systems, designed to meet the needs of clinical diagnostic laboratories in different sectors (oncology, diabetes, hemoglobin pathologies, etc.). Type: | 1 | 1 | 0 | 74 |
 | Electronique du Mazet [Automatic translation follows] Designer and manufacturer of electro-medical devices Electronique du Mazet designs and manufactures electronic products. Specializing in the medical sector, the company takes care of the design and manufacturing of complete products for its customers. It has also developed a range of products intended for physiotherapists and sold under its Mazet Santé brand. Medical Device and Electronic Cards Type: | 1 | 0 | 0 | 36 |
 | Mazet Santé [Automatic translation follows] Your partner in physiotherapy. Do not hesitate to contact us for more information ! Mazet Santé is a brand of the Electronique du Mazet group. Located on the Lignon plateaus in Haute-Loire (near Saint-Etienne) for 40 years, the Electronique du Mazet company has become an expert in the design and manufacture of 100% French medical devices. Our products benefit from CE Medical 0459 certification and the ISO 13485 standard and are mainly dedicated to physiotherapy. You can also find us on Facebook and YouTube. Mazet Santé is a brand of the Electronique du Mazet group. Based in … Type: | 1 | 0 | 0 | 4 |
 | Aguettant France [Automatic translation follows] Essential for life Welcome to the AGUETTANT France LinkedIn page! AGUETTANT is a French family pharmaceutical laboratory, dedicated to the development, manufacturing and marketing of injectable pharmaceutical specialties used or initiated in hospitals. AGUETTANT puts its expertise at the service of progress and medical innovation to design the therapeutic solutions of tomorrow. Find all the news from AGUETTANT France on this page. Anesthesia - Resuscitation, Parenteral Nutrition, Emergency Injectables, Parkinson's Disease, and Spasticity Type: | 3 | 1 | 1 | 42 |
 | CAP COMPLIANCE - LA QUALITE AU COEUR DES INDUSTRIES DE SANTE [Automatic translation follows] ADVICE, AUDIT, SPECIALIZED HEALTH INDUSTRY TRAINING - medical devices, cosmetics, compl. food, med. CAP COMPLIANCE is a consulting company specializing in QUALITY Management. Its core business mainly focuses on consulting activities for the health industries (medicines, medical devices, cosmetics and food supplements). Founded by an independent consultant who has built his professional experience for around fifteen years in the health industries, Cap Compliance is today able to provide you with all the necessary solutions to best comply with industry-related standards and benchmarks. health. ADVICE - AUDIT - TRAINING 🗞CAP COMPLIANCE service offer: We are able to provide … Type: | 3 | 2 | 3 | 5 |
 | CEMA Technologies Technologies for Efficient Tooling For more than 50 years we manufacture multi-cavity molds (>128) for drug delivery devices. plastique, moule d'injection, injection mold, medical, diagnostic, pharmaceutical, design control, and metrology Type: | 6 | 1 | 3 | 33 |
 | TECH4HEALTH [Automatic translation follows] Supporting health technologies throughout their maturation cycle. A network of expertise made up of reactive platforms, which answer the “Why, When and How to carry out preclinical and clinical studies”. The network aims to encourage initiatives and facilitate the realization of multidisciplinary and collaborative translational research projects in the field of evaluation of medical devices, e-Health and biomaterials. It is a national network bringing together academic expertise in regulation and evaluation serving the development of medical devices, e-Health and biomaterials throughout their life cycle. These axes may expand according to needs, strategic issues and network resources. Tech4Health … Type: | 1 | 1 | 0 | 4 |
 | Bionoveo [Automatic translation follows] Research Center & Health Development BIONOVEO offers project leaders, industrial or academic, the biological, technical and methodological skills and resources necessary for the development of new therapeutic and diagnostic strategies, as well as their production processes. Type: | 3 | 1 | 3 | 4 |
 | MEDICAL EXPANSION MEDICAL EXPANSION is a consultancy specialized in supporting the international development of small to medium sized enterprises in the sector of HEALTHCARE. Whether you are in OTC, medical devices, biotech, nutritional supplements, or natural health products, we can bring you tailor-made support and solutions and will obtain tangible results to fulfil your international ambitions. We can deliver on this promise thanks to more than 18 years of experience in international development, with the support of a network of expert associates specialized in healthcare marketing. If you have the will, we have the experience and know-how. So just give us a … Type: | 1 | 1 | 0 | 5 |
 | COLTENE Micro-Mega [Automatic translation follows] 🇫🇷 French designer and manufacturer since 1905 💪 For dental professionals | 🌍 Global Supplier The MICRO-MEGA company, whose original activity dates back to 1905, is internationally recognized for the design, manufacturing and marketing of medical devices intended for dental surgery. Its root canal and obturation instruments, its handpieces and contra-angles and its hygiene devices bear witness to its unique technical and scientific know-how and the impeccable quality of its endodontic products made in France. medical, dentistry, dental, and endodontics Type: | 9 | 1 | 4 | 83 |
 | Asdia [Automatic translation follows] The patient at the heart of our concerns The patient at the heart of our concerns ASDIA was created in Strasbourg in 2002 on the premises of the European Center for the Study of Diabetes (CEED), a research structure aimed at the development of innovative therapies, which could tomorrow relieve or even cure diabetes. This proximity has profoundly conditioned our professional approach, dedicated to supporting the patient in their daily life, while having an eye on their future. Building on this ongoing commitment to patient education and monitoring to ensure the effectiveness of their treatments, we have … Type: | 6 | 1 | 5 | 389 |
 | Santélys [Automatic translation follows] Find a solution at home, whatever the age, level of dependence and state of health of the patients. Recognized as a public utility, Santélys is a non-profit establishment specializing in health, home support and training. Coordination, prevention, education, hospitalization, care, support, technologies, telemedicine and telemonitoring, at home and in local units: Santélys' vocation is to find a solution at home, whatever the age, the level of dependency and the state of health of the patient suffering from a chronic pathology (kidney failure, respiratory failure, diabetes, etc.) or cancer. Training in nursing, training of nursing assistants, continuing education, … Type: | 3 | 2 | 2 | 423 |
 | Pumpinheart Novel Medical Devices to treat Heart Failure with preserved Ejection Fraction (HFpEF) Novel Medical Device to treat Heart Failure with preserved Ejection Fraction Type: | 2 | 0 | 2 | 6 |
 | aVaxziPen aVaxziPen is focusing on next-generation vaccines for infectious diseases and emerging threat pathogens. Type: | 0 | 0 | 0 | N/A |
 | Thermidas Oy Thermal imaging solutions trusted by medical professionals Thermidas Oy is a Finnish health technology company established in 2008. Thermidas' infrared (IR) thermal imaging system is a novel imaging method supporting screening, early diagnostics, and evaluation of treatment effectiveness. At the core of the solution is an easy-to-use thermal imaging application developed by the company. Thermidas' IR thermal imaging system is the first CE-approved medical device IR-thermal imaging system in the world. Thermography, Thermal imaging equipment, Thermal image analysis software, FDA Cleared, and CE 0598 Certified Type: | 2 | 0 | 2 | 15 |
 | Mirai Medical Precision Cancer Therapy - - MedTech Innovator '23 A culture of innovation, a passion for excellence At Mirai Medical, we are passionate about developing technology that greatly improves cancer outcomes and enhances patient experiences. Following intensive research and development, Mirai Medical was formed from a team with over 50 combined years of experience in the areas of pulsed electrical fields, electroporation for cancer, immunotherapy and medical device development to address critical unmet challenges in cancer treatment. We have developed unique IP that allows for outpatient delivery of ePORE therapy which greatly facilitates the ease and improves the outcome of cancer … Type: | 2 | 0 | 0 | 18 |
 | Renovos Biologics Limited Next-generation regenerative medicine solutions, pioneering use of synthetic nanoclay gels for tissue regeneration. Renovos is a new regenerative medicine company capitalising on the decades of world-class stem cell and orthopaedic research from the University of Southampton. Renovos is developing next-generation regenerative medicine solutions, based on a synthetic nanoclay gel technology platform, Renovite. Renovos offers a complementary range of products and services to address the needs of researchers and clinicians, developing solutions for tissue healing that is quicker, safer and more cost-effective. Regenerative Medicine, Biomaterials, Drug Delivery, Medical Devices, Pharmaceuticals, Stem Cells, Cell Based Assays, and Orthopaedics Type: | 0 | 0 | 0 | 11 |
 | Santero Therapeutics A start-up biotech active in the field of antibiotics discovery. Santero Therapeutics is a start-up biotech active in the field of antibiotics discovery. We are developing first-in-class, novel generations of drugs to fight multiple resistant pathogens Type: | 0 | 0 | 0 | 9 |
 | Kinarus Therapeutics Kinarus Therapeutics is a clinical-stage company developing therapies for viral, respiratory and ocular diseases. Kinarus Therapeutics (SIX:KNRS) is a clinical-stage pharmaceutical company focused on bringing novel, patient-focused treatments for viral, respiratory, and ophthalmic diseases. Kinarus was incorporated in Basel, Switzerland in 2017. Our lead drug candidate is an oral combination of a clinical-stage P38 mitogen activated protein kinase (p38 MAPK) inhibitor, in-licensed from Roche, and a second drug, together enabling an oral, long-term effective treatment. Kinarus has launched a large Phase 2 clinical trial in hospitalized Covid-19 patients with the aim to reduce mortality and duration of hospital stay. The … Type: | 0 | 0 | 0 | 5 |
 | Topadur Pharma AG Disruptive Therapies for Aging Diseases Topadur Pharma AG is a Swiss biopharmaceutical start-up based in Schlieren, Zurich. The company was founded in 2015 by experienced scientists that combine several years of expertise in R&D Pharma. Topadur’s vision is to improve patients’ quality of life by providing highly effective and safe drugs for unmet medical conditions. Topadur has discovered and developed new dual-acting drugs that target the cGMP-Enzyme Regulation System to stimulate microcirculation, enable tissue regeneration, and avoid local oxygen deficiency. Based on our key invention we have developed an attractive portfolio of drug candidates to treat aging-related diseases like chronic … Type: | 0 | 0 | 0 | 13 |
 | SEED Biosciences One Click, One Cell We are SEED Biosciences, a spinoff from the Swiss Federal Institute of Technology (EPFL). We make DispenCell. One click, one cell. DISPENCELL is an automated laboratory instrument designed for fast, easy, and gentle single cell isolation. DISPENCELL is a pipetting robot designed to be compact, gentle, and intuitive, yet compliant with the most stringent regulatory standards. Designed by scientists for scientists, DISPENCELL has been thought to quickly integrate your lab routine in a plug-and-play approach. Flexible and effortless, DISPENCELL operates equally under sterile conditions in a culture hood, or on a simple benchtop. Its unique technology … Type: | 1 | 1 | 0 | 16 |
 | iCellate Medical AB Cancer profiling for precision oncology and early cancer detection iCellate develops and provides cancer profiling services for precision oncology. iCellate’s CellMate® is a next generation circulating tumor cell (CTC)-based platform for cancer cell detection and comprehensive biomarker analysis. GeneMate® is an analysis for hereditary cancer and gBRCA testing. Cancer Diagnostics, Circulating Tumor Cells (CTC), Liquid Biopsy, Next Generation Sequencing, CDx, Hereditary Cancer, Early Detection, Cancer, and Solid Tumors Type: | 0 | 0 | 0 | 19 |
 | revyve Simple, sustainable microbial ingredients that unlock the future of food At revyve, we produce simple, sustainable ingredients from circularly sourced microbial biomass like brewers yeast. Our ingredients are highly functional and can perfectly replace E-numbers and animal ingredients. Revyve's ingredients are key to revolutionising the taste and texture of alternative proteins and unlocking the future of food. alternative protein, taste, texture, functionality, and future of food Type: | 3 | 0 | 3 | 27 |
 | iOnctura Developing selective cancer therapies against targets that play critical roles in multiple tumor survival pathways iOnctura is a clinical-stage biotech developing selective cancer therapies against targets that play critical roles in multiple tumor survival pathways such as cellular proliferation; escape from immune detection; and drug resistance. iOnctura’s pioneering approach to drug development is expected to offer significant clinical benefits over the traditional approach of targeting a single pathway alone. iOnctura has progressed two therapeutic candidates into mid-stage clinical development: IOA-244, a highly selective allosteric inhibitor of PI3Kδ to treat Treg-driven tumors; and IOA-289, a highly selective, non-competitive autotaxin (ATX) inhibitor … Type: | 3 | 1 | 2 | 22 |
 | Rosa Biotech Biosensing. Reimagined. Rosa Biotech is an AI-driven biosensing and diagnostics company based in Bristol. Our mission is to provide outcome-focused biosensing for early disease diagnosis and for use in industrial biotechnology. We have developed a novel sensing platform that leverages the rapid and precise approach honed over millions of years in the olfactory systems of mammals. By using machine learning we are capable of discriminating between complex biological samples and are able to predict commercial and clinical outcomes. Biosensing, Diagnostics, AI, Machine learning, Medicines manufacturing, Industrial biotechnology, Biotechnology, Biodesign, Chemistry, Protein design, Peptide design, Sensing, and Detection Type: | 0 | 0 | 0 | 3 |
 | AstriVax Committed to address real-world challenges in vaccinology AstriVax is a privately held spin-off company from the KU Leuven, founded in 2022 based on vaccine technology developed at the Rega Institute. AstriVax is building a first in class Plug & Play vaccine platform with a patented DNA based technology that launches self-amplifying live attenuated viruses. The versatile technology of AstriVax can be used to develop a wide range of vaccines to prevent and treat infectious diseases. AstriVax aims to address major challenges in vaccinology by developing novel vaccines that are easy to produce, have reduced cold chain requirements, and offer broad … Type: | 0 | 0 | 0 | 34 |
 | Lentitek Enabling the next generation of medicines Lentitek is developing solutions to help amazing therapies get to more people. Gene therapies, and gene-modified cell therapies such as CAR-T are proving themselves as incredible life changing and life saving therapies. However they face an issue with the production yield of the viral vector. Lentitek is developing solutions to improve the viral yield by 10 fold and beyond. This will help these developers reduce production costs and allow these amazing therapies get into more people who really need it! Type: | 1 | 0 | 1 | 3 |
 | Anavo Therapeutics BV UNLOCKING THE PHOSPHATASE TARGET CLASS Anavo Therapeutics is the first company to systematically drug phosphatases, a rich target space previously considered undruggable for decades. We have attracted world-leading scientific expertise in phosphatase-driven disease biology and drug discovery to unlock the full potential of phosphatase-targeted allosteric modulators. In oncology, Anavo is developing multiple first-in-class therapeutic programs and will build on partnerships around its platform to establish a rich pipeline across several indications. Anavo is backed by blue-chip investors M Ventures, INKEF Capital, Taiho Ventures, and Bioqube Ventures. drug discovery, phospatase biology, and oncology Type: | 0 | 0 | 0 | 25 |
 | MUVON Therapeutics AG Regain control with personalized muscle regeneration MUVON Therapeutics is a clinical stage Life Science spin-off from the University of Zurich developing a therapeutic platform for the regeneration of skeletal muscle tissue based on autologous cells, not only repairing damaged tissue but also increasing the regenerative potential of weakened muscles. Our initial area of focus is the treatment of stress urinary incontinence in women, supporting them respectfully throughout their journey to a healthy life. Type: | 0 | 0 | 0 | 19 |
 | Halo Therapeutics We develop pan-coronavirus antivirals The DeepTech Health Company Biotechnology, Virology, Antivirals, Small Molecule Drugs, Drug Development, and Pharmaceuticals Type: | 4 | 0 | 4 | 4 |
 | Oniria Therapeutics A shift in cancer treatment methodology makes a world of difference. A shift in cancer treatment methodology makes a world of difference. Oniria Therapeutics is a spin-off from Vall d'Hebron Institute of Oncology (VHIO), the University of Barcelona (UB) and the Catalan Institution for Research and Advanced Studies (ICREA). Oniria Therapeutics is a biotech company focused on the development of first-in-class drugs in the field of precision oncology. It develops therapies to modulate and eliminate dormant tumor cells as a novel targeted strategy to overcome their persistence. Our flagship product allosterically activates TET2, a master epigenetic enzyme. Biotechnology, cancer, cell … Type: | 3 | 0 | 2 | 14 |
 | smartbax Developing novel multi-targeted antibiotics with extraordinary potency against multi-drug resistant bacteria. smartbax develops novel multi-targeted, antibacterial compounds with extraordinary potency against multi-drug resistant bacteria and difficult-to-treat biofilms. With the first-in-class compounds, the company targets the multi-drug resistant pathogens methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-resistant enterococci (VRE). Type: | 2 | 0 | 2 | 4 |
 | Anocca Engineered Immunity Anocca understands the complexity of T-cell biology. We have established a unique technology platform that replicates functional human cellular immunobiology and unlocks the potential of T-cell immunotherapies and vaccine strategies that leverage T-cell immunity. Anocca’s approach and proprietary technologies deliver the means to efficiently and precisely harness and manipulate T-cell immunity, enabling a range of next-generation therapies and vaccination strategies that address unmet patient need in oncology, infectious disease and autoimmunity. Today Anocca has a focus on delivering T-cell receptor-modified T-cell therapies (TCR-T) in oncology. Anocca is rapidly progressing a pipeline of novel therapeutic TCR-T candidates generated entirely … Type: | 0 | 0 | 0 | 98 |
 | Saphenus Medical Technology [Automatic translation follows] A new therapy for less pain and safer walking after amputation. With the Suralis sensory feedback system. Saphenus is a manufacturer of sensory feedback systems with the aim of improving the quality of life of people with leg and foot prostheses. “The prosthesis should adapt to the person and not the other way around” is one of the core messages from Saphenus. Saphenus has developed a multi-stage therapy specifically for people who have lost a limb and complain of pain, which combats pain and at the same time increases the quality of their gait. Saphenus works with … Type: | 1 | 1 | 0 | 16 |
 | Capitainer Convenient and quantitative blood sampling at the fingertip for everyone, everywhere at anytime. We have developed a microsystem based technology that offers a solution for near-patient blood sampling e.g. at home. Patients can themselves conveniently leave blood samples (as dried blod spots) and send it by mail to a laboratory for analysis. This is possible through our new disposable sampling chip that can meter and store an exact blood volume which allows for quantitative measurements, something that so far not has been possible. This is of particular importance for patients requiring continuous therapeutic drug monitoring. Our technology will reduce the … Type: | 2 | 0 | 2 | 27 |
 | Diamyd Medical Developing precision medicine therapies for Type 1 Diabetes Diamyd Medical is a Swedish diabetes company developing precision medicine therapies for Type 1 Diabetes. The therapeutic diabetes vaccine Diamyd , an antigen-specific immunotherapy for the preservation of endogenous insulin production, is being evaluated in the ongoing Phase III trial DIAGNODE-3. The company is establishing a vaccine manufacturing facility in Umeå for the manufacture of recombinant GAD65, the active ingredient in the diabetes vaccine. Diamyd Medical also develops the GABA-based investigational drug Remygen® as a therapy for regeneration of endogenous insulin production and to improve hormonal response to hypoglycaemia. Diamyd Medical is … Type: | 3 | 0 | 2 | 39 |
 | InflaRx N.V. An innovative biopharmaceutical company developing anti-inflammatory therapeutics by targeting the complement system. InflaRx (Nasdaq: IFRX) is a clinical-stage biopharmaceutical company focused on applying its proprietary anti-C5a technology to discover and develop first-in-class, potent and specific inhibitors of C5a. Complement C5a is a powerful inflammatory mediator involved in the progression of a wide variety of autoimmune and other inflammatory diseases. InflaRx was founded in 2007 and the group has offices and subsidiaries in Jena and Munich, Germany, as well as Ann Arbor, MI USA. Type: | 1 | 0 | 1 | 50 |
 | FoodSquared The Future of Shellfish | We’re fundraising! FoodSquared is a B2B FoodTech company using a “patent pending” process and proprietary ingredient formulations to create next generation plant-based shellfish, starting with plant-based shrimp. Farmed shrimp have the largest carbon footprint per 100g protein after beef. We want to make that transition to plant-based shrimp easy by making great tasting and healthy alternatives. Our shrimp not only looks, tastes and feels like a native shrimp but our innovative process and ingredients also allows our product to benchmark the protein content and nutritional profile of a native shrimp unlike other plant-based shrimp products … Type: | 1 | 0 | 1 | 3 |
 | HEARTNET | Techstars '23 Solving fake and falsified medicines. Solving the $200billion epidemic of fake and falsified medicine Trade in counterfeited and falsified drugs has reached over 200 Billion dollars and the WHO warns that this problem is going to get worse. Hundreds of thousands of deaths are caused by faked and falsified drugs in Africa every year. We help Pharmaceuticals comply with track and trace to fight fake and falsified drugs. Type: | 1 | 0 | 1 | 3 |
 | LiberaBio Addressing "undruggable" oncology targets by delivering whole antibodies inside the tumor and metastatic cells. LiberaBio is a preclinical stage biotech that develops new oncology treatments based on the proprietary MPN technology. This nanotechnology actively targets tumor and metastatic cells and delivers small and large molecules to on-surface or intracellular targets. The company is creating new treatments by delivering novel antibodies targeting intracellular oncoproteins. Oncology, Nanomedicine, Drug delivery, Antibodies, Biosimilars, Active targeting, Intracellular, Oncoproteins, and Cytotoxics Type: | 2 | 0 | 2 | 11 |
 | PD Neurotechnology Ltd. Medical solutions PD Neurotechnology Ltd is a high-tech medical device company, founded in London, UK. The Greek Branch is based in Athens, Greece and the main activity of the company is carried out in the R&D and production, which is located in Ioannina, Greece. The company focuses its activities on researching, developing, producing and selling wearable medical devices and solutions for monitoring and supporting treatment of movement disorders. Its first solution is PDMonitor which is a sophisticated expert eco-system for patients with Parkinson’s Disease. Type: | 0 | 0 | 0 | 28 |
 | NUCAPS 🔬 New encapsulation technology for the industrial development of Nanocapsules and Biocapsules 💊 Green Nanotechnology NUCAPS@ is a consortium comprised by two Pharmaceutical companies (Laboratorios Cinfa and IDIFARMA), a Food Technological Center (CNTA) and the University of Navarra. T his consortium has developed new solutions based on the use of Food proteins (GRAS) as casein, zein or soya for the oral delivery and controlled release of drugs/actives and/or microorganisms. Nanotechnology, Encapsulation, Nanoencapsulation, Microencapsulation, Food, Nutrition, Cosmetic, Farmaceutic, and Pharmaceutical Type: | 3 | 1 | 3 | 21 |
 | SynaptixBio Ltd. Developing therapies for severe leukodystrophies Overview SynaptixBio is a rare disease biotech company that is pioneering ground-breaking treatments for severe leukodystrophies and other childhood neurodegenerative diseases. SynaptixBio’s mission is to deliver gene therapies for fatal leukodystrophies in children caused by loss of function or mutation in a single gene. Using a breadth of platforms including antisense oligonucleotide (ASO)-based technology, we can silence the expression of the toxic gene to reverse disease progression. This approach will create life saving treatments for severe genetic diseases that affect the central nervous system. Pharmaceutical, Biotech, Leukodystrophy, Rare Disease, H-ABC, Hypomyelination, Basal Ganglia, Cerebrllum, Neurology, … Type: | 2 | 0 | 2 | 3 |
 | MicroHarvest Championing future protein, harnessing the power of microorganisms Pushing boundaries to drive Impact! Championing the future of protein through microorganisms Building Smaller, Better, Faster Hamburg & Lisbon Join us, we are hiring! Type: | 10 | 4 | 9 | 28 |
 | Phialogics - The immune tolerance company Our R&D platform is focused on developing immune modulating therapeutics for patients with autoimmune diseases. Our immune checkpoint activators protect patient’s organ tissue. Unique approach : - Potential for BEST-in-class super agonist against immune-mediated tissue damage - High selectivity for active T-cells - Proof of concept in relevant human in vitro models and mouse model of disease Type: | 1 | 0 | 1 | 6 |
 | PureIMS 🫁 Improving the health and lives of patients through effective, safe and convenient inhaled drug delivery PureIMS is a clinical stage pharmaceutical company focused on developing and commercializing innovative inhaled therapies, based on its proprietary dry powder inhaler Cyclops®. The focus is on the treatment of systemic and respiratory diseases with significant unmet medical need. The company’s leadership team consists of seasoned life sciences executives who bring long-lasting and complementary experience in leading drug development, addressing applicable scientific issues and pursuing commercial and business development & licensing opportunities. They obtained their experience in leading positions with mid-size and top-5 global … Type: | 0 | 0 | 0 | 10 |
 | Mosaic TX An oncology therapeutics company dedicated to resolving cancer’s complexity to power new treatments for patients. ABOUT US Mosaic Therapeutics is an oncology therapeutics company using advanced computational methods and next-generation cancer models to discover and develop novel targeted therapies. The company’s main mission is to tackle cancers with substantial unmet need by reinventing the traditional approach to target and drug discovery. Born out of pioneering research at the Wellcome Sanger Institute in collaboration with the Netherlands Cancer Institute, and anchored around a proprietary platform that has seen 20 years of fine-tuning and development, Mosaic has active programmes across a variety … Type: | 2 | 1 | 1 | 31 |
 | Alia Therapeutics On-target gene therapies Alia Therapeutics, the first Italian CRISPR company, is developing new therapeutic approaches to treat incurable genetic diseases. Alia’s unique CRISPR-based genome editing tools allow unprecedented specificity in modifying the genome, coupled with safe and efficient delivery into target cells. Alia’s gene editing platform overcomes relevant limitations speeding up the development of genetic medicines. Type: | 0 | 0 | 0 | 14 |
 | Moolec Science Science in Food Ingredients We are a science-based ingredient company leader in the use of Molecular Farming technology for food and dietary supplementation markets. Our mission is to create unique food ingredients by engineering plants with animal protein genes. Moolec’s technological approach aims to have the cost structure of plant-based solutions with the nutrition and functionality of animal-based ones. Our technology has been under development for more than a decade and is known for pioneering the production of a bovine protein in a crop for the food industry. The Company’s product portfolio and pipeline leverages the agronomic efficiency of broadly … Type: | 3 | 1 | 2 | 17 |
 | Adcendo ADCs, Copenhagen, Denmark. Adcendo seeks to develop antibody-drug conjugates to create new medicines for cancer patients with a significant unmet need. The company was founded in 2017 in Copenhagen, as a spin-out from The Finsen Laboratory of Rigshospitalet and the University of Copenhagen. Type: | 0 | 0 | 0 | 42 |
 | hemotune AG We are a Swiss company on a mission to combat sepsis through magnetic blood purification. Member of @Wyss Zurich. We are a start-up medical device company originating from ETH Zurich and are passionate about developing life saving therapies. Our mission is to develop a breakthrough medical device for the most urgent healthcare issues. Focusing on patients’ needs, we translate the most promising research to the clinics and ensure patient access to scientific progress as soon as possible. As pioneers we take courageous decisions and are shaping the future of medicine. We first focus on finding an efficient therapy for patients … Type: | 3 | 0 | 1 | 26 |
 | Neurosoft Bioelectronics Soft implantable brain computer interfaces At Neurosoft Bioelectronics, we strive at improving the care of patients who suffer from neurological disorders by developing soft implantable electrodes to interface with the nervous system. We have established a unique technology that allows to manufacture extremely compliant neural interfaces that can achieve long-term bio-integration in the body. These devices will improve therapeutic outcomes in patients as well as open up new applications for neural interfaces that were so far impossible. Type: | 3 | 2 | 2 | 16 |
 | Hylomorph preventing post-operative complications in implantable medical devices Hylomorph is an innovative Medtech company engineering biomaterials to optimize the interface between implants and their surrounding biological tissues. We aim at preventing post operative complications in implantable medical devices. Our mission is to improve quality of life in patients and the quality of care by health professionals. Our proprietary CellSense technology was developed in the cutting-edge laboratories of the Swiss Federal Institute of Technology (ETH Zurich). Hylomorph's first product, Hylomate, has demonstrated outstanding performance in limiting the foreign body reaction and fibrotic buildup in pre-clinical settings and is currently undergoing first-in-man … Type: | 1 | 0 | 1 | 13 |
 | CUTISS AG Personalized & bioengineered human skin tissue therapy for patients with severe burns and skin injuries Our mission: to give patients back more of their own skin to make them well again. CUTISS is a Swiss clinical-stage life sciences company focussed on regenerative medicine, skin tissue engineering, and skin pigmentation. We are developing the first personalized and automated skin tissue therapy offering life-saving and life-changing medical treatments for patients with severe skin injuries. Our lead product denovoSkin promises to take skin surgery to the next level and revolutionize current treatments. It is a bio-engineered and personalized dermo-epidermal human skin graft, currently … Type: | 6 | 1 | 5 | 54 |
 | EggField Science driven protein company focusing on egg alternatives and helping gastronomy and industry to plant based growth. Pflanzliche Ei-Alternativen vom Feld für Industrie und Gastronomie. natürlich - clean label - ökologisch - vegan - swiss made Type: | 3 | 2 | 1 | 10 |
 | Ariceum Therapeutics Developing novel drugs for systemic targeted radiotherapy (STR) Ariceum Therapeutics is a private clinical-stage radiopharmaceutical company focused on the diagnosis and precision treatment of neuroendocrine and certain other aggressive, hard-to-treat cancers. Our lead targeted systemic radiopharmaceutical product, 177 Lu-satoreotide tetraxetan (Satoreotide), is an antagonist of the somatostatin type 2 receptor (SSTR2) which is overexpressed in many neuroendocrine tumours. We are developing satoreotide as a ‘theranostic’ pair for the combined diagnosis and targeted radionuclide treatment of neuroendocrine cancers, certain aggressive tumours and childhood cancer, which currently has few treatment options and a poor prognosis. Ariceum Therapeutics was launched in 2021, following … Type: | 1 | 1 | 1 | 34 |
 | Alentis Therapeutics We develop breakthrough treatments for Claudin1-positive tumors and organ fibrosis Alentis Therapeutics, the Claudin-1 (CLDN1) company, is a clinical stage biotechnology company on a mission to develop first-in-class antibodies and ADCs for CLDN1+ tumors and organ fibrosis. Alentis is pioneering a novel approach to modify and reverse the course of disease progression targeting CLDN1, a previously unexploited target that plays a key role in the pathology of tumors and fibrotic diseases across multiple organs. Alentis is the only company developing potential treatments for solid cancers and fibrosis targeting CLDN1. Alentis’ portfolio of anti-CLDN1 monoclonal antibodies includes a novel class of … Type: | 6 | 0 | 0 | 59 |
 | NunaBio Limited Synthetic DNA production for cutting-edge biotechnology solutions. NunaBio is a privately-owned specialist DNA synthesis and development company. We are engaged in CRO (Contract Research Organizations) and CDMO (Contract Development and Manufacturing Organisation) activities. The company has built a solid reputation for its R&D flexibility and innovative approach to complex and challenging projects. NunaBio’s core expertise is research and development into cell-free DNA synthesis, process optimisation, route design, scale-up and small-scale manufacture for clinical studies. DNA, Custom DNA, Gene Synthesis, Synthetic Biology, Biotechnology, and DNA Synthesis Type: | 4 | 0 | 3 | 20 |
 | Manus Neurodynamica Prioritising Parkinson's Disease and other neurological conditions with earlier diagnosis and appropriate care. Manus Neurodynamica is revolutionising health care management by developing and patenting neuroscience technologies that record recognised biomarkers of neuromotor impairments which can radically improve patient diagnosis and disease monitoring. Our disruptive technology has potential to be used across applications such as screening, rehabilitation and drug development and medicine optimisation, streamlining referrals, reducing costs and increasing the efficiency of specialist services. We are looking for interested researchers, clinicians and practitioners to collaborate in situ assessment and testing of the NeuroMotor pen, as well as investors for the further … Type: | 1 | 0 | 1 | 16 |
 | CHARM Therapeutics Harnessing the power of deep learning to deliver therapeutics of transformational efficacy for patients. CHARM Therapeutics is discovering and developing small molecule medicines against difficult-to-drug targets with our proprietary 3D deep learning-enabled platform, DragonFold. Powered by the first high throughput protein-ligand co-folding algorithm and a world-class team of scientists and engineers, CHARM seeks to deliver innovative approaches to create life-changing therapies for patients. Type: | 4 | 0 | 4 | 60 |
 | Complement Therapeutics Developing the next generation of complement medicines Complement Therapeutics GmbH (CTx) is an early-stage biotechnology company focused on the research and development of novel therapeutics for complement-mediated diseases. The Company is a spinout from the University of Manchester and is based on the pioneering research of its founders into novel targets within the complement cascade. Our lead investigational product (CTx001) is being evaluated as a potential gene therapy for dry age-related macular degeneration/geographic atrophy, a leading cause of blindness. Additional programmes will evaluate potential therapeutic opportunities in other complement-mediated conditions. The Company is also developing a unique quantification methodology, the … Type: | 2 | 0 | 2 | 28 |
 | Curileum Discovery Ltd Curileum is intervening early in serious gastrointestinal (GI) disease development with novel diagnostics & therapeutics Curileum is intervening early in serious GI disease development with novel therapeutics to detect and correct cell production in the gut mucosa Biotechnology Type: | 0 | 0 | 0 | 5 |
 | TC BioPharm Treating cancer with γδ T cells | Nasdaq Ticker - $TCBP TC BioPharm is a publicly traded, clinical-stage cell therapy company developing advanced allogeneic CAR-T cell therapy products for the treatment of cancer, as well as developing gamma delta T cell therapies for the treatment of infectious disease. We have a growing team based in our Glasgow office, alongside a wide range of scientific advisors, and partner organisations. Clinical Grade Cell Therapy, Cancer Immonotherapy, Regenerative Medicine, and Stratified Medicine Type: | 0 | 0 | 0 | 56 |
 | Arcede Pharma Aiming to provide improved treatments for chronic respiratory diseases through new, innovative drug substances Aiming to provide improved treatments for chronic respiratory diseases through new, innovative and patent protected substances, thereby reducing suffering and ameliorating quality of life for patients. Type: | 0 | 0 | 0 | 3 |
 | Samplix Reveal cell function with single-cell resolution. Samplix offers a cutting-edge droplet-based instrument for single-cell analysis in immunotherapy research. Our double emulsion technology enables seamless analysis and sorting on flow cytometers. Empower your research today! Xdrop encapsulates living cells and reactive molecules in highly stable double-emulsion droplets that act as microenvironments for rapid cell–cell and cell–molecule interactions during incubation. The droplets are suitable for flow cytometry and sorting. Xdrop Sort can both generate and sort double-emulsion droplets in a user-friendly workflow that does not require any experience with fluorescence-based cell sorters. The limited volume forces fast interactions and causes secreted substances … Type: | 2 | 0 | 2 | 38 |
 | InSphero Reliable, reproducible, and scalable 3D in vitro platforms for drug safety & efficacy testing | The Model of ExcellenceTM InSphero is the only 3D in vitro model company with the platform and expertise to modernize drug safety and efficacy testing in a way that empowers researchers to reach their full potential. Our innovative spheroid-based models allow for more effective and safe therapies to get to the clinic faster due to our superior robustness, reliability, reproducibility, and scalability. InSphero’s goal is to help researchers fuel a new era of drug discovery through comprehensive products and services for: - Liver safety - … Type: | 3 | 0 | 0 | 72 |
 | New Wave Biotech Unleashing biotech innovation for a greener and fairer future For those creating a more sustainable future with biotechnology, we use AI and computational modelling to help precision fermentation alt protein companies optimise their downstream processing, so they can de-risk their ventures, speed up R&D and reduce costs. Biotechnology, Bioprocessing, Biomanufacturing, Precision Fermetation, ClimateTech, Alternative Protein, Computational Modelling, and Downstream Processing Type: | 7 | 2 | 5 | 6 |
 | Gearbox Biosciences Antibiotic-free recombinant protein production technology in E. coli Antibiotic-free protein production in E. coli protein production and synthetic biology Type: | 0 | 0 | 0 | 4 |
 | ATANIS Biotech AG We revolutionize allergy diagnosis ATANIS Biotech AG has been incorporated as a spin-off company from the University of Bern by the four co-founders Mrs. Noemi Zbären, Prof. Thomas Kaufmann, Prof. Alexander Eggel and Prof. Jean-Pierre Kinet in Summer 2021. The company has developed a novel functional cell based assay that massively simplifies the diagnosis of allergies and can predict treatment success of therapies. This test will additionally be used to assess safety and efficacy of potential new drug candidates for allergy treatment as well as for the evaluation of allergenicity of various food products. The proprietary assay is offered through … Type: | 0 | 0 | 0 | 11 |
 | Nemysis Ltd We are focussed on nutritional and pharmaceutical solutions to cope with Iron Deficiency/Anemia and Gluten Intolerance Based in Dublin, we are a highly focused team of senior individuals, with established networks and track records of research, entrepreneurial and investment success. Nemysis Ltd, a healthcare and pharmaceutical company, is focussed on nutritional and pharmaceutical solutions that can protect against some of the negative consequences of nutrient deficiency, nutrient intolerances and sensitivities, paying particular attention to the need to safeguard the human microbiome. · Nemysis' novel nanoparticulate iron is the first natural ferritin mimic, which can correct human iron deficiency and Anemia, … Type: | 0 | 0 | 0 | 7 |
 | Delmic Powerful insights, simple workflows Delmic is a passionate high-tech company based in Delft, the Netherlands that develops powerful and user-friendly solutions for electron microscopy, bringing researchers and organizations closer to research insights across diverse application fields. Integration of light and electron microscopy fundamentally impacts imaging by creating the possibility to gain deep insight quickly, easily and reliably. Delmic’s mission is to empower researchers and companies by helping them achieve results that can be trusted implicitly with powerful and user-friendly solutions. Currently, Delmic has two main product lines: cathodoluminescence solutions (SPARC Spectral, SPARC Compact and JOLT) and correlative light and electron … Type: | 2 | 0 | 1 | 58 |
 | Aurealis Therapeutics Multi-target cell and gene therapies for unmet medical needs. Aurealis Therapeutics is a Swiss-Nordic Cell and Gene Therapy Platform Company. Our multi-target cell and gene therapy platform, based on genetically modified safe lactic acid bacteria, addresses unmet medical needs: Chronic Wounds - Diabetic Foot Ulcers, Venous Ulcers, Pressure Ulcers - deadly Cancers - Ovarian Cancer, Peritoneal Carcinomatosis - Inflammation. After successfully completing our Phase 1 clinical study in Diabetic Foot Ulcer (DFU) patients with our lead clinical product AUP-16, our DFU Phase 2 study is ongoing in Italy, Germany and Poland. Venous Ulcers and other ulcers will follow. In Oncology, … Type: | 1 | 0 | 1 | 18 |
 | Atrandi Biosciences | Droplet Genomics Microfluidics, Single-Cell Analysis, & High-Throughput Screening Atrandi Biosciences is breaking new ground in high-throughput analysis technologies. Providing simple-to-adopt and easy-to-use droplet microfluidics and high-throughput screening (HTS) workflows. Droplet microfluidics technology is at the core of our products and provides an unmatched platform for exploring the complexity of biology in a high-throughput manner. Droplet microfluidics enables compartmentalizing molecular biology reactions into millions of pico-liter droplets, empowering you to study biological samples at the resolution of single cells and single molecules. Our work is at the intersection of life sciences, engineering, and machine learning. We deliver elegant solutions and novel tools for … Type: | 2 | 1 | 1 | 52 |
 | Sirius Medical Moving from localization to Surgical Marker Navigation Sirius Medical is dedicated to improving care for cancer patients by delivery of unsurpassed, yet affordable solutions that enable precise and efficient removal of tumors. The company is a spin-off of the Netherlands Cancer Institute, where researchers recognized the need to simplify and improve localization technology for the surgical removal of breast cancers. This led to the development and clinical demonstration of the first magnetic seed localization, a technique that Sirius Medical perfected and further developed into the Sirius Pintuition System. Today, Sirius Pintuition represents the next generation of tumor localization technology, known … Type: | 0 | 0 | 0 | 35 |
 | Sensible Biotechnologies Engineering cells to make better mRNA. At Sensible Biotechnologies, we are turning living cells into cost-efficient factories for manufacturing high-quality mRNA to unlock the full potential of mRNA therapeutics and vaccines. Type: | 1 | 0 | 1 | 15 |
 | HBOX Therapies Delivering therapies through targeted hyperoxygenation We are developing miniaturized hyperoxygenation therapies! The first application for our technology is miniaturized respiratory assist in patients suffering from lung failure. Type: | 2 | 0 | 2 | 5 |
 | SOMAÍ Pharmaceuticals We Craft Care At SOMAÍ, we are on a journey to build a leading global brand with the most robust portfolio of innovative cannabis-based therapeutics. We envision a world where people live healthy lifestyles empowered by natural cannabis medicine. Our company is dedicated to formulating innovative cannabis-based products to ensure a healthy and comfortable life. For that, we create a wide variety of medications for chronic patients and different conditions. We aim to design calm and satisfactory experience of administering, prescribing and purchasing cannabis-based medicine. SOMAÍ Pharmaceuticals is an EU-GMP European pharmaceutical and biotech company centered on manufacturing in Lisbon, … Type: | 0 | 0 | 0 | 40 |
 | LightOx Ltd Light Activated Technologies for treating cancers and rare diseases Lightox has developed a new drug for the treatment of early stage oral cancers. The topically applied formulation allows for specific delivery to the lesion and is activated by a specific wavelength of light. Type: | 0 | 0 | 0 | 13 |
 | Mnemo Therapeutics Mnemo Therapeutics is a biotechnology company focused on discovering and developing immune based therapies, including powerful cell therapies, that create accessible cures for solid tumors and blood cancers. Its EnfiniT platform, a groundbreaking drug discovery engine, leverages a new class of antigens with greater tumor specificity and a suite of technologies to significantly improve T cell memory, persistence, and sensitivity. The result is dramatic improvement in the body’s immune response to overcome disease. Mnemo is built by a global team of scientists and biotech leaders united in their mission to create the most powerful immune therapies to deliver accessible cures … Tags: FrenchTech120 Type: | 4 | 3 | 2 | 41 |
 | Resilience [Automatic translation follows] Better treatment of cancer thanks to digital technology Resilience is a company dedicated to remote monitoring and support for oncology patients whose mission is to better treat cancer. Through synergistic tools intended for patients and those who care for them, Resilience provides a global solution aimed at humanizing, streamlining and personalizing care pathways. The Resilience mobile application supports people affected by cancer on a daily basis to help them cope better with the side effects caused by their treatments and improve their quality of life. The Resilience remote monitoring platform, a class IIa medical device, allows healthcare … Tags: FrenchTech2030 Type: | 37 | 25 | 20 | 155 |
 | Lys Therapeutics First-in-class biotherapies against neurological diseases. Targeting neuroinflammation to tackle neurodegeneration. Lys Therapeutics is a biotechnology company pioneering a breakthrough approach to treat patients suffering from neurodegenerative or neurovascular disorders. Its main drug is a first-in-class monoclonal antibody, Glunozumab, displaying an exclusive and groundbreaking mechanism of action. It is demonstrated that one endogenous protease called tissue plasminogen activator (tPA) is implicated in the pathophysiology of neurological diseases such as multiple sclerosis, Parkinson’s disease, stroke and other neurodegenerative disorders through its overexpression and binding to NMDA receptors (NMDAr) present on vascular endothelial cells and regulating the blood brain barrier (BBB) function / … Type: | 13 | 4 | 8 | 12 |
 | Vivet Therapeutics Vivet Therapeutics is dedicated to developing innovative gene therapy treatments for orphan diseases. Vivet Therapeutics is focused on optimizing gene therapy through collaborating with the Fundacion para la Investigacion Medica Aplicada (CIMA, Universidad de Navarra) to develop new AAV vectors specifically targeting the liver and generating new technologies to optimize gene delivery and long term expression. Gene Therapy Type: | 2 | 0 | 1 | 31 |
 | Fox Innovation [Automatic translation follows] Relieve the back, preserve your health Personalized support for choosing the appropriate exoskeleton Fox Innovation is a company founded in 2017. Coming from the medical world, she supports employees and companies in their search for ergonomic solutions and prevention of the risks of musculoskeletal disorders (MSD). From job analysis, on-site testing to certified training in the use of these innovative technologies, Fox Innovation has acquired recognized experience on exoskeletons installed today in France in all areas and for a very large number of different positions and professions Fox Innovation involves more than 650 company visits and more … Type: | 7 | 1 | 4 | 4 |
 | GlioCure A preclinical-stage drug-development company specialized in neuro-oncology GlioCure, a spin-off company of Angers and McGill Montreal universities, aims to treat glioblastoma that causes 200,000 deaths worldwide each year. To overcome this challenge, GlioCure is hyper-specialized and develops glioblastoma-specific drugs. GlioCure is currently focusing on the development of GC01, an anti-glioblastoma peptide discovered by Joël Eyer, Director of Research from INSERM, and covered by two patent families for which GlioCure owns worldwide exclusive rights. GlioCure's team has the experience and the know-how to ensure the successful completion of GC01’s development plan: Louis-Marie is a biotech entrepreneur with 15 years of experience … Type: | 4 | 2 | 2 | 5 |
Startup